| # | Country | Total Patents | |
|---|---|---|---|
| #1 | United States | 5 | |
| #2 | Australia | 4 | |
| #3 | WIPO (World Intellectual Property Organization) | 3 | |
| #4 | Canada | 2 | |
| #5 | EPO (European Patent Office) | 2 | |
| #6 | Japan | 1 | |
| #7 | South Africa | 1 |
| # | Industry | |
|---|---|---|
| #1 | Organic fine chemistry | |
| #2 | Pharmaceuticals |
| # | Technology | |
|---|---|---|
| #1 | Therapeutic chemical compounds | |
| #2 | Heterocyclic compounds | |
| #3 | Special acyclic compounds |
| # | Name | Total Patents |
|---|---|---|
| #1 | Kelley James L | 16 |
| #2 | Krenitsky Thomas A | 16 |
| #3 | Beauchamp Lilia M | 11 |
| #4 | Beauchamp Lilia | 5 |
| #5 | Heyer Dennis | 2 |
| #6 | White Helen Lyng | 2 |
| #7 | Harfenist Morton | 2 |
| #8 | Boros Eric | 2 |
| Publication | Filing date | Title |
|---|---|---|
| US7205297B2 | Substituted 5-alkynyl pyrimidines having neurotrophic activity | |
| CA2369945A1 | Neurotrophic thio substituted pyrimidines | |
| US6583148B1 | Neurotrophic substituted pyrimidines | |
| US6440965B1 | Substituted pyrimidine derivatives, their preparation and their use in the treatment of neurodegenerative or neurological disorders of the central nervous system | |
| US6110961A | Phenoxathin derivatives as inhibitors of monoamine oxidase |